Safrin Ali
Physician Assistant · Spring, TXNPI 1083084503
Payments from drug & device makers
Across 130 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$462
- Medtronic$357
- Abbott$303
- Corcept Therapeutics$152
- Lilly USA, LLC$149
- Tandem Diabetes Care, Inc.$84
- plus $730 from 21 others
What the payments were for
- Food & beverage$2,22599%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $462 |
| Medtronic | 15 | $357 |
| Abbott | 23 | $303 |
| Corcept Therapeutics | 7 | $152 |
| Lilly USA, LLC | 8 | $149 |
| Tandem Diabetes Care, Inc. | 4 | $84 |
| Dexcom, Inc. | 4 | $76 |
| Sequel Med Tech, LLC | 2 | $70 |
| AbbVie | 4 | $59 |
| Xeris Pharmaceuticals, Inc. | 4 | $58 |
| Radius Health, Inc. | 2 | $50 |
| Amphastar Pharmaceuticals, Inc. | 3 | $50 |
| Tolmar, Inc. | 2 | $40 |
| Insulet Corporation | 2 | $36 |
| AstraZeneca | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Averitas Pharma Inc. | 2 | $28 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Antares Pharma, Inc. | 1 | $25 |
| Zealand Pharma US, Inc. | 1 | $23 |
| BETA Bionics, Inc. | 1 | $23 |
| Bigfoot Biomedical Inc | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Merck | 1 | $18 |
| Astellas Pharma US Inc | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
How this compares
$2,237 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 90 | $157,477 |
| MounjaroTirzepatide | 38 | $61,860 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 40 | $46,529 |
| JardianceEmpagliflozin | 29 | $23,886 |
| TrulicityDulaglutide | 12 | $23,172 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $23,046 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $20,360 |
| Humulin R U-500Insulin Regular, Human | 11 | $17,941 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $17,510 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $15,000 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 12 | $13,002 |
| Novolog FlexpenInsulin Aspart | 28 | $11,951 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $8,969 |
| NovologInsulin Aspart | 19 | $6,817 |
| InvokanaCanagliflozin | 11 | $6,203 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $462 | $164,294109 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $149 | $89,17261 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $26 | $46,52940 claims |
| Boehringer IngelheimJardiance | $19 | $23,88629 claims |
| MerckJanumet Xr | $18 | $15,00011 claims |
| AbbVieSynthroid | $59 | $3,31240 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $19 | $1,219128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Spring
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.